CTOR Citius Oncology, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · citiusonc.com

0.8510USD+0.12%Mkt Cap: 90.00M $P/E: —1d ago

Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed…

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited

$58.68BUSD

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB (publ)

$14.43BUSDP/E 112.9

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporated

$11.17BUSD

RDY

Dr. Reddy's Laboratories Limited

Hims & Hers Health, Inc.

$6.89BUSD

AMRX

Amneal Pharmaceuticals, Inc.

$6.84BUSDP/E 40.1

Key Statistics

Company

Market Cap90.00M USD

Enterprise Value83.54M USD

Revenue (TTM)7.11M USD

Gross Profit5.32M USD

Net Income (TTM)-24.76M USD

Revenue/Share0.08 USD

Last Price0.8510 USD

Fiscal Year EndSep 2025

MR QuarterJun 2026

Employees—

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue11.76

P/S12.65

P/B2.23

EPS (TTM)-0.47

EPS (Forward)—

52W Range

0.491020% of range2.250

52W High2.250 USD

52W Low0.4910 USD

Profitability

Gross Margin74.82%

Oper. Margin-595.55%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-55.19%

ROA-24.53%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-5.49M USD

CapEx (TTM)5.75M USD

FCF Margin-438.66%

FCF Yield-34.63%

Net Debt-6.35M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.08

Current Ratio0.73

Quick Ratio0.29

Book Value/Sh0.38 USD

Cash/Share0.16 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)4.000 USD

Upside (mean)+370.0%

Target Range4.000 USD – 4.000 USD

# Analysts1

Ownership

Shares Out.105.76M

Float30.98M

Insiders77.51%

Institutions15.21%

Short Interest

Short Ratio7.3d

Short % Float1.72%

Short % Out.0.48%

Shares Short509.54K

Short (prev mo.)452.41K

Technical

SMA 500.8336 (+2.1%)

SMA 2000.8756 (-2.8%)

Beta3.40

S&P 52W Chg16.45%

Avg Vol (30d)94.81K

Avg Vol (10d)96.00K

Technical Indicators

RSI (14)44.1

MACD0.0213

MACD Signal0.0515

MACD Hist.-0.0302

BB Upper1.139 USD

BB Middle0.9726 USD

BB Lower0.8062 USD

BB Width34.23%

ATR (14)0.0927 USD

Vol Ratio (20d)0.90x